These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30279703)

  • 1. Corrigendum: Emergence of Members of TRAF and DUB of Ubiquitin Proteasome System in the Regulation of Hypertrophic Cardiomyopathy.
    Gupta I; Varshney NK; Khan S
    Front Genet; 2018; 9():409. PubMed ID: 30279703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of Members of TRAF and DUB of Ubiquitin Proteasome System in the Regulation of Hypertrophic Cardiomyopathy.
    Gupta I; Varshney NK; Khan S
    Front Genet; 2018; 9():336. PubMed ID: 30186311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.
    Poirson J; Biquand E; Straub ML; Cassonnet P; Nominé Y; Jones L; van der Werf S; Travé G; Zanier K; Jacob Y; Demeret C; Masson M
    FEBS J; 2017 Oct; 284(19):3171-3201. PubMed ID: 28786561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Deubiquitinating Enzyme Inhibition and Applications in Cancer Therapeutics.
    Antao AM; Tyagi A; Kim KS; Ramakrishna S
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32549302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deubiquitylation of deubiquitylases.
    Haq S; Ramakrishna S
    Open Biol; 2017 Jun; 7(6):. PubMed ID: 28659380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DUBs, New Members in the Hypoxia Signaling clUb.
    Schober AS; Berra E
    Front Oncol; 2016; 6():53. PubMed ID: 27014628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A portrayal of E3 ubiquitin ligases and deubiquitylases in cancer.
    Satija YK; Bhardwaj A; Das S
    Int J Cancer; 2013 Dec; 133(12):2759-68. PubMed ID: 23436247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deubiquitinases (DUBs) and DUB inhibitors: a patent review.
    Farshi P; Deshmukh RR; Nwankwo JO; Arkwright RT; Cvek B; Liu J; Dou QP
    Expert Opin Ther Pat; 2015; 25(10):1191-1208. PubMed ID: 26077642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DUBs, Hypoxia, and Cancer.
    Mennerich D; Kubaichuk K; Kietzmann T
    Trends Cancer; 2019 Oct; 5(10):632-653. PubMed ID: 31706510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ubiquitin-proteasome system and sperm DNA repair: An update].
    Zhang GW; Cai HC; Shang XJ
    Zhonghua Nan Ke Xue; 2016 Sep; 22(9):834-837. PubMed ID: 29071883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 stability is regulated by diverse deubiquitinating enzymes.
    Kwon SK; Saindane M; Baek KH
    Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):404-411. PubMed ID: 28801249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme reversal to explore the function of yeast E3 ubiquitin-ligases.
    MacDonald C; Winistorfer S; Pope RM; Wright ME; Piper RC
    Traffic; 2017 Jul; 18(7):465-484. PubMed ID: 28382714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Ubiquitin Proteasome System in Ischemic and Dilated Cardiomyopathy.
    Spänig S; Kellermann K; Dieterlen MT; Noack T; Lehmann S; Borger MA; Garbade J; Barac YD; Emrich F
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31861129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promising new therapeutic targets for regulation of inflammation and immunity: RING-type E3 ubiquitin ligases.
    Bulatov E; Valiullina A; Sayarova R; Rizvanov A
    Immunol Lett; 2018 Oct; 202():44-51. PubMed ID: 30099009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitination and deubiquitination emerge as players in idiopathic pulmonary fibrosis pathogenesis and treatment.
    Li S; Zhao J; Shang D; Kass DJ; Zhao Y
    JCI Insight; 2018 May; 3(10):. PubMed ID: 29769446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The E3 ubiquitin ligase Asb2β is downregulated in a mouse model of hypertrophic cardiomyopathy and targets desmin for proteasomal degradation.
    Thottakara T; Friedrich FW; Reischmann S; Braumann S; Schlossarek S; Krämer E; Juhr D; Schlüter H; van der Velden J; Münch J; Patten M; Eschenhagen T; Moog-Lutz C; Carrier L
    J Mol Cell Cardiol; 2015 Oct; 87():214-24. PubMed ID: 26343497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of E3 ubiquitin ligases in insulin resistance.
    Yang XD; Xiang DX; Yang YY
    Diabetes Obes Metab; 2016 Aug; 18(8):747-54. PubMed ID: 27097743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hidden targets of ubiquitin proteasome system: To prevent diabetic nephropathy.
    Goru SK; Kadakol A; Gaikwad AB
    Pharmacol Res; 2017 Jun; 120():170-179. PubMed ID: 28363724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel strategies to target the ubiquitin proteasome system in multiple myeloma.
    Lub S; Maes K; Menu E; De Bruyne E; Vanderkerken K; Van Valckenborgh E
    Oncotarget; 2016 Feb; 7(6):6521-37. PubMed ID: 26695547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of E3 ubiquitin ligases in gastric cancer.
    Hou YC; Deng JY
    World J Gastroenterol; 2015 Jan; 21(3):786-93. PubMed ID: 25624711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.